Laxido Orange

Macrogol 3350, the active ingredient in Laxido Orange, is an osmotic laxative presented as a powder for solution for oral use. It is used to relieve occasional and chronic constipation by increasing intestinal water content, softening stool and promoting regular bowel movements in adults and children across the European market. The formulation also contains electrolytes to help maintain fluid balance.

GNH USA supplies Laxido Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing regulated manufacturing, quality assurance and reliable logistics for global distribution.

Laxido Orange, an osmotic laxative, is indicated for conditions affecting bowel transit and stool consistency.

- Constipation: helps relieve occasional or chronic constipation by softening stool and promoting regular bowel movements. - Opioid‑induced constipation: alleviates reduced gastrointestinal motility caused by opioid therapy, restoring normal stool passage. - Functional bowel disorders: assists in managing functional constipation associated with irritable bowel syndrome, improving stool frequency and consistency.

Laxido Orange may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Abdominal cramps - Diarrhoea - Increased thirst

Serious or Rare Side Effects: - Electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Severe dehydration - Allergic reactions such as rash, urticaria or angioedema - Severe abdominal pain - Rectal bleeding - Persistent vomiting

Before using Laxido Orange, consider the following precautions.

- Renal function assessment: evaluate kidney function in patients with renal impairment. - Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance. - Bowel obstruction: avoid use in individuals with known or suspected intestinal blockage. - Hypersensitivity: discontinue if allergic reactions occur. - Elderly patients: start with the lowest effective dose and monitor tolerance. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture.

Laxido Orange can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives (e.g., polyethylene glycol 4000) may cause excessive fluid loss. - Use with potent diuretics can exacerbate electrolyte depletion. - Combination with mineral oil may increase the risk of intestinal impaction.

Moderate Interactions (Monitor Closely): - Anticholinergic agents that reduce gut motility may lessen efficacy. - Certain antibiotics (e.g., tetracyclines) may have reduced absorption when taken with laxatives. - Medications requiring stable electrolyte levels (e.g., digoxin) should be monitored.